Lantern Pharma competitors

Lantern Pharma Competitors include BenevolentAI, CytomX Therapeutics, Lescarden and Xenetic Biosciences.
Add company...
Lantern Pharma
Lantern Pharma
Lantern Pharma develops novel targeted cancer therapeutics.
BenevolentAI
BenevolentAI
BenevolentAI harnesses artificial intelligence to enhance and accelerate scientific discovery by making sense of highly fragmented information to create new insights and usable knowledge that benefit society.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Lescarden
Lescarden
Lescarden Inc. researches, tests, develops, and sells medications for the control and cure of various diseases with a focus on wound healing, clinical skin care, osteoarthritis and cancer applications.
Xenetic Biosciences
Xenetic Biosciences
Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics.
Founding Date
Founding Date
2013
Founding Date
2013
Founding Date
2008
Founding Date
1960
Founding Date
2011
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dallas, US HQ
Locations
Greater London, GB HQ
Antwerpen, BE
Brooklyn, US
Locations
South San Francisco, US HQ
Locations
New York, US HQ
Locations
Lexington, US HQ
Employees
Employees
8
Employees
1582% increase
Employees
92
Employees
1
Employees
529% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
838.9 m
Valuation ($)
3.5 k
Valuation ($)
19.1 m
Twitter followers
Twitter followers
44
Twitter followers
2.3 k
Twitter followers
385
Twitter followers
N/A
Twitter followers
346

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$71.6m (FY, 2017)
Revenue (est.)
$119.7k (FY, 2016)
Revenue (est.)
$7.6m (FY, 2017)
Net income
Net income
N/A
Net income
N/A
Net income
($43.1m) (FY, 2017)
Net income
($112.7k) (FY, 2016)
Net income
($3.6m) (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 3.7m (almost 2 years ago)
Latest funding round
$ 115m (10 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 4.7m
Total funding raised
$ 215m
Total funding raised
$ 132.4m
Total funding raised
N/A
Total funding raised
$ 10m
For sources of this data, please see the company profileDownload Excel

View company profiles

BenevolentAI
HQ
Greater London, GB
Employees
158↑ 2% increase

BenevolentAI harnesses artificial intelligence to enhance and accelerate scientific discovery by making sense of highly fragmented information to create new insights and usable knowledge that benefit society.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
92

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
Lescarden
HQ
New York, US
Employees
1

Lescarden Inc. researches, tests, develops, and sells medications for the control and cure of various diseases with a focus on wound healing, clinical skin care, osteoarthritis and cancer applications.

View company
Xenetic Biosciences
HQ
Lexington, US
Employees
5↓ 29% decrease

Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics.

View company